Jonathan Bliggenstorfer to Neoadjuvant Therapy
This is a "connection" page, showing publications Jonathan Bliggenstorfer has written about Neoadjuvant Therapy.
Connection Strength
1.043
-
Bliggenstorfer JT, Bingmer K, Ofshteyn A, Stein SL, Charles R, Steinhagen E. Neoadjuvant radiation above NCCN guidelines for rectal cancer is associated with age under 50 and early clinical stage. Surg Endosc. 2022 05; 36(5):2925-2935.
Score: 0.681
-
Chang C, Bliggenstorfer JT, Liu J, Shearer J, Dreher P, Bingmer K, Stein SL, Steinhagen E. Not All Patients With Locally Advanced Rectal Cancer Benefit From Neoadjuvant Therapy. Am Surg. 2023 Nov; 89(11):4327-4333.
Score: 0.183
-
Bliggenstorfer JT, Ginesi M, Steinhagen E, Stein SL. Lymph node yield after rectal resection is a predictor of survival among patients with node-negative rectal adenocarcinoma. Surgery. 2022 Nov; 172(5):1292-1299.
Score: 0.179